Literature DB >> 4172047

Treatment of carcinoma of the head and neck with intravenous methotrexate.

L A Leone, M M Albala, V B Rege.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4172047     DOI： 10.1002/1097-0142(196805)21:5<828::aid-cncr2820210507>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  Methotrexate in the treatment of malignant tumours: evidence for the possible participation of host defence mechanisms.

Authors:  T H Stewart; D Klassen; A F Crook
Journal:  Can Med Assoc J       Date:  1969-08-23       Impact factor: 8.262

Review 2.  Head and neck cancer: guidelines for chemotherapy.

Authors:  G Catimel
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 3.  Current role of chemotherapy in head and neck cancer.

Authors:  J S Tobias
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

4.  Oral dipyridamole and methotrexate in human solid tumors: a toxicity trial.

Authors:  C S Higano; R B Livingston
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 5.  Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers.

Authors:  Przemysław Koźmiński; Paweł Krzysztof Halik; Raphael Chesori; Ewa Gniazdowska
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

6.  Intra-arterial infusion with methotrexate in the rat.

Authors:  P J Sindram; G B Snow; L M van Putten
Journal:  Br J Cancer       Date:  1974-10       Impact factor: 7.640

7.  Results in fifty cases of advanced squamous cell carcinoma of the head and neck treated by intravenous chemotherapy.

Authors:  T J Priestman
Journal:  Br J Cancer       Date:  1973-05       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.